drugset / Trial / NCT03274440

Effects of Marijuana on Symptoms of OCD

NCT03274440

Phase 1/2 Completed 14 enrolled New York State Psychiatric Institute
RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this pilot research study is to test whether certain components of the marijuana plant, known as "cannabinoids", may help to reduce symptoms in patients with OCD. Specifically, patients enrolled in the study will smoke marijuana containing different concentrations of 2 different cannabinoids, THC and CBD. Both of these agents act on the brain's "endocannabinoid system," which has been hypothesized to play a role in OCD. Neither compound is currently FDA-approved for treating OCD.

Timeline

Start
2017-10-01
Primary completion
2019-03-01
Completion
2020-10-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabis Traditional medicine (herbal / TCM) Other